11 research outputs found
The impact of glaucoma on quality of life in Ethiopia: a case-control study.
BACKGROUND: Glaucoma is a chronic disease characterized by irreversible optic nerve damage and visual field loss that leads to visual impairment and blindness; ultimately limiting personal independence and compromising overall quality of life of affected individuals. There is paucity of information on how glaucoma affects the quality of life of patients in low and middle-income countries where resources for both diagnosis and treatment of such conditions are limited. In this study we investigate the impact of glaucoma on quality of life in Ethiopian patients. METHODS: The quality of life of 307 glaucoma patients and 76 normal controls that were frequency matched to the age and sex profiles of the cases was assessed using Amharic version of Glaucoma Quality of Life -15 questionnaire. Linear regression models and the t-test were employed to compare significant differences in GQL-15 scores and to generate mean and mean differences between cases and controls respectively. RESULTS: The mean GQL-15 score in the glaucoma cases was substantially higher (indicating poorer quality of life) than the controls [cases 46.3 (95% CI, 28.8-63.8) and controls 18.6 (95% CI, 15.2-22.0), p < 0.0001]. Cases with normal visual acuity and mild glaucoma had significantly higher scores than the controls. Poorer quality of life was associated with age ≥ 71 years old 51.1 (95%CI, 26.2-75.9), rural residence 55.7 (95%CI, 49.9-61.5), monthly income of <400 Birr (53.1; 95%CI, 50.5-55.6), diagnosis time 1-5 years (49.6; 95%CI, 41.2-57.9), severe visual impairment (70.5; 95%CI, 58.1-82.8), and advanced glaucoma (50.9; 95%CI, 43.6-58.3). CONCLUSION: These glaucoma patients, including those with normal visual acuity and early disease, had poorer quality of life compared to normal controls. Older age, rural residence, low income and more advanced disease were significantly associated with poorer quality of life. There is a need to increase awareness of the impact of glaucoma among clinicians, patients and their families, for a better understanding of the impact this disease has on a person's life
Delayed initiation of antenatal care and associated factors in Ethiopia: a systematic review and meta-analysis
Prevalence of trachoma at sub-district level in Ethiopia : determining when to stop mass azithromycin distribution
To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts. Prevalence surveys to assess impact at the district level are recommended after at least 3 years of intervention. The decision to stop MDA is based on a prevalence of trachomatous inflammation follicular (TF) among children aged 1-9 years below 5% at the sub-district level, as determined by an additional round of surveys limited within districts where TF prevalence is below 10%. We conducted impact surveys powered to estimate prevalence simultaneously at the sub-district and district in two zones of Amhara, Ethiopia to determine whether MDA could be stopped.; Seventy-two separate population-based, sub-district surveys were conducted in 25 districts. In each survey all residents from 10 randomly selected clusters were screened for clinical signs of trachoma. Data were weighted according to selection probabilities and adjusted for correlation due to clustering.; Overall, 89,735 residents were registered from 21,327 households of whom 72,452 people (80.7%) were examined. The prevalence of TF in children aged 1-9 years was below 5% in six sub-districts and two districts. Sub-district level prevalence of TF in children aged 1-9 years ranged from 0.9-76.9% and district-level from 0.9-67.0%. In only one district was the prevalence of trichiasis below 0.1%.; The experience from these zones in Ethiopia demonstrates that impact assessments designed to give a prevalence estimate of TF at sub-district level are possible, although the scale of the work was challenging. Given the assessed district-level prevalence of TF, sub-district-level surveys would have been warranted in only five districts. Interpretation was not as simple as stopping MDA in sub-districts below 5% given programmatic challenges of exempting sub-districts from a highly regarded programme and the proximity of hyper-endemic sub-districts
Sample description in South Wollo and South Gondar by <i>woreda</i> (district) and sub-district evaluation unit (EU).
<p>*Sub-district evaluation unit (EU).</p><p>** excluding 1.8% and 0.4% of households in South Wollo and South Gondar for which consent was not given.</p
Distribution of trachomatous inflammation folliclar (TF) among children aged 1–9 years in Amhara National Regional State, Ethiopia.
<p>Data are stratified by <i>woreda</i> and evaluation unit.</p
Administrative levels and respective population structure of Amhara National Regional State, Ethiopia.
<p>Administrative levels and respective population structure of Amhara National Regional State, Ethiopia.</p
Surveyed communities in South Gondar and South Wollo zones of Amhara National Regional State, Ethiopia.
<p>Surveyed communities in South Gondar and South Wollo zones of Amhara National Regional State, Ethiopia.</p
Summary of survey findings and recommended programmatic strategy for trachoma elimination in South Wollo and South Gondar Zone, Ethiopia.
<p>*Sub-district evaluation unit (EU).</p>‡<p>Interpretation of WHO guidelines.</p
Prevalence of active trachoma and clinical signs among children aged 1–9 years in Amhara National Regional State, Ethiopia.
<p>Data are shown for the years 2003, 2006, and 2010–2011.</p